Nate Crossett

Stock Analyst at Exane BNP Paribas

(2.47)
# 2,387
Out of 4,761 analysts
37
Total ratings
52%
Success rate
1.02%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Jul 2, 2024
Downgrades: Neutral
Price Target: $6$4
Current: $4.87
Upside: -17.86%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $35.70
Upside: -15.97%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $72.83
Upside: -12.12%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $14.31
Upside: +18.80%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $57.09
Upside: +10.35%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $95.57
Upside: +13.01%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $66.08
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $165.36
Upside: -16.55%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $120.97
Upside: +16.56%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $49.12
Upside: +28.26%
Initiates: Underperform
Price Target: $42
Current: $41.38
Upside: +1.50%
Initiates: Outperform
Price Target: $41
Current: $31.28
Upside: +31.07%
Initiates: Outperform
Price Target: $29
Current: $31.88
Upside: -9.03%
Initiates: Underperform
Price Target: $74
Current: $61.64
Upside: +20.05%
Initiates: Outperform
Price Target: n/a
Current: $16.83
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.25
Upside: +32.41%
Initiates: Outperform
Price Target: $66
Current: $91.78
Upside: -28.09%
Initiates: Outperform
Price Target: $38
Current: $22.09
Upside: +72.02%
Initiates: Outperform
Price Target: $886
Current: $919.68
Upside: -3.66%
Downgrades: Hold
Price Target: $31$30
Current: $27.97
Upside: +7.26%
Initiates: Buy
Price Target: $21
Current: $4.33
Upside: +384.99%
Downgrades: Hold
Price Target: $21$25
Current: $11.11
Upside: +125.12%
Upgrades: Buy
Price Target: n/a
Current: $44.76
Upside: -